Lista de obras - Muthiah Vaduganathan - Dominio Público Uruguay

A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial

scientific article published on 01 November 2019

Anticoagulation in heart failure: current status and future direction

artículo científico publicado en 2013

Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review

artículo científico publicado en 2016

Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial

article

Availability and Use of Shared Data From Cardiometabolic Clinical Trials.

artículo científico publicado en 2017

Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX).

artículo científico publicado en 2017

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

artículo científico publicado en 2017

Cardiovascular clinical trials with noninferiority or equivalence designs from 2001 to 2012.

artículo científico publicado en 2016

Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial

artículo científico

Changes in Serum Potassium Levels During Hospitalization in Patients With Worsening Heart Failure and Reduced Ejection Fraction (from the EVEREST Trial)

Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial

artículo científico

Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial

artículo científico publicado en 2014

Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVERE

article

Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations

artículo científico

Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies

artículo científico publicado en 2015

Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012).

artículo científico publicado en 2015

Contrasting acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trial.

artículo científico publicado en 2015

Coronary artery disease in patients with heart failure: incidental, coincidental, or a target for therapy?

artículo científico publicado en 2014

Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure

artículo científico

Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries

artículo científico publicado en 2014

Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?

scientific article published on 01 March 2019

Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis

artículo científico publicado en 2017

Drug therapy to reduce early readmission risk in heart failure: ready for prime time?

artículo científico publicado en 2013

Effects of renin–angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2023

Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial

artículo científico publicado en 2016

Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment

article

Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review

artículo científico publicado en 2018

Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials

artículo científico publicado en 2016

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

article by Catherine Owens Johnson et al published March 2019 in Lancet Neurology

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Dise

artículo científico publicado en 2018

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial

artículo científico publicado en 2013

Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

scientific article published on 10 July 2019

Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues

scientific article published on 16 December 2019

Hemoconcentration-guided diuresis in heart failure

artículo científico publicado en 2014

High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.

artículo científico publicado en 2018

History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure

artículo científico publicado en 2018

Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.

artículo científico publicado en 2016

Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial

artículo científico publicado en 2012

Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial

artículo científico publicado en 2019

Lipids, statins, and clinical outcomes in heart failure: rethinking the data

artículo científico publicado en 2014

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Medicaid Expansion and Utilization of Antihyperglycemic Therapies

scientific article published on 04 September 2020

Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial)

artículo científico publicado en 2014

Mode of Death in Heart Failure With Preserved Ejection Fraction

artículo científico publicado en 2017

One-Year Outcomes After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Varying Quantities of Coronary Artery Calcium (from a 13-Year Registry).

artículo científico publicado en 2016

Pectus Excavatum and Right Ventricular Compression in a Young Athlete with Syncope

scientific article published on 01 August 2018

Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

artículo científico publicado en 2018

Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial

artículo científico publicado en 2017

Predictive Value of Low Relative Lymphocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

article

Prognostic Value of Monocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations

artículo científico publicado en 2013

Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).

artículo científico publicado en 2012

Progress or lack of progress in hospitalized heart failure.

artículo científico publicado en 2013

Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics', clinicians', industry's, regulators', and payers' perspectives

artículo científico

Rehospitalization for heart failure: problems and perspectives

artículo científico publicado en 2012

Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial)

scientific article published on 06 November 2018

Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial).

artículo científico publicado en 2013

Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).

artículo científico publicado en 2014

Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial

artículo científico publicado en 2012

Reply

Reply: effect of ivabradine on early readmissions after hospitalization for worsening heart failure

artículo científico publicado en 2015

Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF

scientific article published on 09 October 2019

Risk of Cardiovascular Hospitalizations from Exposure to Coarse Particulate Matter (PM10) Below the European Union Safety Threshold.

artículo científico publicado en 2016

Roadmap to inpatient heart failure management

artículo científico publicado en 2015

Safety and Tolerability of Transitioning from Cangrelor to Ticagrelor in Patients Who Underwent Percutaneous Coronary Intervention.

artículo científico publicado en 2017

Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure

artículo científico publicado en 2016

Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials

artículo científico publicado en 2017

Site selection for heart failure clinical trials in the USA.

artículo científico publicado en 2015

Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

artículo científico publicado en 2014

Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

Targeting sudden death in heart failure with preserved ejection fraction: promise or pipedream?

article

The Reply

artículo científico publicado en 2018

The Reply

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

artículo científico publicado en 2014

The potential role of nonpharmacologic electrophysiology-based interventions in improving outcomes in patients hospitalized for heart failure

artículo científico

The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial.

artículo científico publicado en 2013

The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions

artículo científico publicado en 2014

The vulnerable phase after hospitalization for heart failure

artículo científico

Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory

scientific article published on 09 December 2020

Trends in Heart Failure Clinical Trials From 2001-2012.

artículo científico

Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials

artículo científico publicado en 2016

Unsolved challenges in diuretic therapy for acute heart failure: a focus on diuretic response

artículo científico publicado en 2015

Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial

scientific article published on June 2016

Water and sodium in heart failure: a spotlight on congestion

artículo científico publicado en 2015

Lista de obras de Muthiah Vaduganathan

A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial

Anticoagulation in heart failure: current status and future direction

Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review

Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial

Availability and Use of Shared Data From Cardiometabolic Clinical Trials.

Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX).

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Cardiovascular clinical trials with noninferiority or equivalence designs from 2001 to 2012.

Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial

Changes in Serum Potassium Levels During Hospitalization in Patients With Worsening Heart Failure and Reduced Ejection Fraction (from the EVEREST Trial)

Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial

Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial

Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVERE

Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations

Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies

Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012).

Contrasting acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trial.

Coronary artery disease in patients with heart failure: incidental, coincidental, or a target for therapy?

Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure

Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries

Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?

Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis

Drug therapy to reduce early readmission risk in heart failure: ready for prime time?

Effects of renin–angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials

Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial

Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment

Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review

Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials

Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Dise

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial

Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues

Hemoconcentration-guided diuresis in heart failure

High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.

History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure

Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.

Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial

Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial

Lipids, statins, and clinical outcomes in heart failure: rethinking the data

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

Medicaid Expansion and Utilization of Antihyperglycemic Therapies

Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial)

Mode of Death in Heart Failure With Preserved Ejection Fraction

One-Year Outcomes After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Varying Quantities of Coronary Artery Calcium (from a 13-Year Registry).

Pectus Excavatum and Right Ventricular Compression in a Young Athlete with Syncope

Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017

Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial

Predictive Value of Low Relative Lymphocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

Prognostic Value of Monocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations

Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).

Progress or lack of progress in hospitalized heart failure.

Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics', clinicians', industry's, regulators', and payers' perspectives

Rehospitalization for heart failure: problems and perspectives

Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial)

Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial).

Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).

Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial

Reply

Reply: effect of ivabradine on early readmissions after hospitalization for worsening heart failure

Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF

Risk of Cardiovascular Hospitalizations from Exposure to Coarse Particulate Matter (PM10) Below the European Union Safety Threshold.

Roadmap to inpatient heart failure management

Safety and Tolerability of Transitioning from Cangrelor to Ticagrelor in Patients Who Underwent Percutaneous Coronary Intervention.

Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure

Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials

Site selection for heart failure clinical trials in the USA.

Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

Targeting sudden death in heart failure with preserved ejection fraction: promise or pipedream?

The Reply

The Reply

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

The potential role of nonpharmacologic electrophysiology-based interventions in improving outcomes in patients hospitalized for heart failure

The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial.